Literature DB >> 1950471

Reduced natural killer cell activity in patients with dementia of the Alzheimer type.

S Araga1, H Kagimoto, K Funamoto, K Takahashi.   

Abstract

We examined the natural killer (NK) cell activity in 50 patients with dementia of the Alzheimer type (DAT) and 37 age-matched normal controls. The NK cell activity in DAT was significantly lower than in the normal controls. The NK cell activity induced by either interferon-alpha (IFN-alpha) or interleukin-2 (IL-2) in DAT was also significantly lower than in the normal controls. There were no significant differences in the level of serum IL-2 and IFN-alpha between the two groups. As regards NK cell subsets, two-color flow cytometric analysis showed no significant differences between the percentages of Leu-11+ Leu-7- cells, Leu-11+ Leu-7+ cells and Leu-11- Leu-7+ cells in the two groups. Our results suggest that NK cells in DAT may have functional abnormalities and may provide important clues to fundamental cellular and molecular aberrations in DAT.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1950471     DOI: 10.1111/j.1600-0404.1991.tb04948.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  8 in total

1.  Association of Peripheral Lymphocyte Subsets with Cognitive Decline and Dementia: The Cardiovascular Health Study.

Authors:  Alison E Fohner; Colleen M Sitlani; Petra Buzkova; Margaret F Doyle; Xiaojuan Liu; Joshua C Bis; Annette Fitzpatrick; Susan R Heckbert; Sally A Huber; Lewis Kuller; William T Longstreth; Matthew J Feinstein; Matthew Freiberg; Nels C Olson; Sudha Seshadri; Oscar Lopez; Michelle C Odden; Russell P Tracy; Bruce M Psaty; Joseph A Delaney; James S Floyd
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

Review 2.  CREB signals as PBMC-based biomarkers of cognitive dysfunction: A novel perspective of the brain-immune axis.

Authors:  Nancy Bartolotti; Orly Lazarov
Journal:  Brain Behav Immun       Date:  2019-01-12       Impact factor: 7.217

Review 3.  Can peripheral leukocytes be used as Alzheimer's disease biomarkers?

Authors:  Kavon Rezai-Zadeh; David Gate; Christine A Szekely; Terrence Town
Journal:  Expert Rev Neurother       Date:  2009-11       Impact factor: 4.618

4.  Immune cells lacking Y chromosome show dysregulation of autosomal gene expression.

Authors:  Hanna Davies; Edyta Rychlicka-Buniowska; Jonas Mattisson; Behrooz Torabi Moghadam; Jan P Dumanski; Jonatan Halvardson; Noemi Nagy; Kazimierz Węglarczyk; Karolina Bukowska-Strakova; Marcus Danielsson; Paweł Olszewski; Arkadiusz Piotrowski; Erin Oerton; Aleksandra Ambicka; Marcin Przewoźnik; Łukasz Bełch; Tomasz Grodzicki; Piotr L Chłosta; Stefan Imreh; Vilmantas Giedraitis; Lena Kilander; Jessica Nordlund; Adam Ameur; Ulf Gyllensten; Åsa Johansson; Alicja Józkowicz; Maciej Siedlar; Alicja Klich-Rączka; Janusz Jaszczyński; Stefan Enroth; Jarosław Baran; Martin Ingelsson; John R B Perry; Janusz Ryś; Lars A Forsberg
Journal:  Cell Mol Life Sci       Date:  2021-04-10       Impact factor: 9.261

5.  Replication of the association of HLA-B7 with Alzheimer's disease: a role for homozygosity?

Authors:  Donald J Lehmann; Martin C N M Barnardo; Susan Fuggle; Isabel Quiroga; Andrew Sutherland; Donald R Warden; Lin Barnetson; Roger Horton; Stephan Beck; A David Smith
Journal:  J Neuroinflammation       Date:  2006-12-18       Impact factor: 8.322

6.  Rps27a might act as a controller of microglia activation in triggering neurodegenerative diseases.

Authors:  Nasibeh Khayer; Mehdi Mirzaie; Sayed-Amir Marashi; Maryam Jalessi
Journal:  PLoS One       Date:  2020-09-17       Impact factor: 3.240

Review 7.  Immunosenescence of Natural Killer Cells, Inflammation, and Alzheimer's Disease.

Authors:  Corona Solana; Raquel Tarazona; Rafael Solana
Journal:  Int J Alzheimers Dis       Date:  2018-11-01

8.  Impairment of Several Immune Functions and Redox State in Blood Cells of Alzheimer's Disease Patients. Relevant Role of Neutrophils in Oxidative Stress.

Authors:  Carmen Vida; Irene Martinez de Toda; Antonio Garrido; Eva Carro; José Antonio Molina; Mónica De la Fuente
Journal:  Front Immunol       Date:  2018-01-11       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.